1naresh2naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
[433783ad-ffe6-4e50-a472-cfa9d5003245] => Array
(
[runtime-id] => 433783ad-ffe6-4e50-a472-cfa9d5003245
[type] => toll-free-key
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[9d298d0a-8214-4a73-988f-9dd4bce56e55] => Array
(
[runtime-id] => 9d298d0a-8214-4a73-988f-9dd4bce56e55
[type] => toll-free-key
)
)
[credentials] => Array
(
[method] => toll-free-key
[value] => tf_ipsecsha;29ce7c6037eb8ba8037832354040786a41273c5d
)
)
)
1naresh2nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => OpenAccess
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
[4a1e7661-ea06-4ee0-ac14-b70f226c934a] => Array
(
[runtime-id] => 4a1e7661-ea06-4ee0-ac14-b70f226c934a
[type] => toll-free-key
[service-id] => ajnr-ac.highwire.org
[access-type] => OpenAccess
[privilege] => Array
(
[0608a791-dbe9-417d-acd8-ea7813cbc07d] => Array
(
[runtime-id] => 0608a791-dbe9-417d-acd8-ea7813cbc07d
[type] => toll-free-key
)
)
[credentials] => Array
(
[method] => toll-free-key
[value] => tf_ipsecsha;29ce7c6037eb8ba8037832354040786a41273c5d
)
)
)
RT Journal Article
SR Electronic
T1 Gadolinium Contrast Agents for CNS Imaging: Current Concepts and Clinical Evidence
JF American Journal of Neuroradiology
JO Am. J. Neuroradiol.
FD American Society of Neuroradiology
SP 2215
OP 2226
DO 10.3174/ajnr.A3917
VO 35
IS 12
A1 Kanal, E.
A1 Maravilla, K.
A1 Rowley, H.A.
YR 2014
UL http://www.ajnr.org/content/35/12/2215.abstract
AB SUMMARY: The aim of this article was to review the properties of the various gadolinium-based contrast agents used for CNS imaging along with the clinical evidence and published data that highlight the impact these different properties can have on diagnostic performance. In addition, approaches to optimizing image acquisition that take into account the different properties of specific gadolinium-based contrast agents and an extensive review of the safety profiles of the various agents are presented. CEcontrast-enhancedCNRcontrast-to-noise ratioGBCAgadolinium-based contrast agentGdgadoliniumNSFnephrogenic systemic fibrosisrCBVrelative cerebral blood volumerCBFrelative cerebral blood flow